A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice.

A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice.
复制标题

细胞周期依赖性 BRCA1-UHRF1 级联调节 DNA 双链断裂修复途径的选择。

DOI:
10.1038/ncomms10201
复制
发表时间:
2016-01-05
影响因子:
16.6
通讯作者:
Pei H
Pei H
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Zhang H;Liu H;Chen Y;Yang X;Wang P;Liu T;Deng M;Qin B;Correia C;Lee S;Kim J;Sparks M;Nair AA;Evans DL;Kalari KR;Zhang P;Wang L;You Z;Kaufmann SH;Lou Z;Pei H

文献摘要

被引文献

相似文献

BRCA1是DNA损伤反应的重要介质,可促进同源重组(homologous recombination, HR),并在S/G2期拮抗53bp1依赖性非同源末端连接。但如何实现这一目标仍不清楚。在这里,我们报道了E3泛素连接酶UHRF1(泛素样,具有PHD和RING finger结构域1)直接参与BRCA1和53BP1之间的相互作用。机制上,UHRF1在S期被BRCA1招募到DNA双链断裂(DSBs)中,这需要BRCA1的BRCT结构域和UHRF1的磷酸化Ser674。随后,UHRF1介导k63连接的RIF1多泛素化,并导致其与53BP1和dsb分离,从而促进HR的启动。因此,UHRF1是DSB修复选择的关键调节因子,这与其在异染色质形成和表观遗传调节中的作用是分开的。BRCA1是DNA双链断裂修复的关键调控因子,具有促进同源重组和抑制非同源末端连接的功能。在这里,作者表明,泛素连接酶UHRF1被BRCA1招募到断裂,在那里它靶向RIF1,从而促进重组。
BRCA1 is an important mediator of the DNA damage response, which promotes homologous recombination (HR) and antagonizes 53BP1-dependent non-homologous end joining in S/G2 phase. But how this is achieved remains unclear. Here, we report that the E3 ubiquitin ligase UHRF1 (Ubiquitin-like, with PHD and RING finger domains 1) directly participates in the interplay between BRCA1 and 53BP1. Mechanistically, UHRF1 is recruited to DNA double-strand breaks (DSBs) by BRCA1 in S phase, which requires the BRCT domain of BRCA1 and phosphorylated Ser674 of UHRF1. Subsequently, UHRF1 mediates K63-linked polyubiquitination of RIF1, and results in its dissociation from 53BP1 and DSBs thereby facilitating HR initiation. Thus, UHRF1 is a key regulator of DSB repair choice, which is separate from its role in heterochromatin formation and epigenetic regulator. BRCA1 is a key regulator of DNA double-strand break repair, functioning to promote homologous recombination and repress non-homologous end-joining. Here the authors show that the ubiquitin ligase UHRF1 is recruited to breaks by BRCA1, where it targets RIF1 and thereby facilitates recombination.